Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W H Benjamin

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Infection and Immunity|September 19, 2000
Human C-reactive protein is protective against fatal Salmonella enterica serovar typhimurium infection in transgenic miceA J Szalai, J L VanCott, J R McGhee, et al.
Microbial Pathogenesis|September 11, 1992
A 'safe-site' for Salmonella typhimurium is within splenic polymorphonuclear cellsN E Dunlap, W H Benjamin, A K Berry, et al.
Chest|December 18, 2001
Value of Mycobacterium tuberculosis fingerprinting as a tool in a rural state surveillance programK G Dobbs, K H Lok, F Bruce, et al.
Cancer Research|April 25, 1992
In vivo administration of bryostatin 1, a protein kinase C activator, decreases murine resistance to Salmonella typhimuriumA S Kraft, V Adler, P Hall, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 28, 1999
Spot sputum screening: evaluation of an intervention in two homeless sheltersM E Kimerling, C F Shakes, R Carlisle, et al.
International Journal of Antimicrobial Agents|December 12, 2001
In vitro activity of ABT-773, telithromycin and eight other antimicrobials against erythromycin-resistant Streptococcus pneumoniae respiratory isolates of childrenC N Johnson, W H Benjamin, B M Gray, et al.
Cancer Research|June 15, 1993
In vivo administration of the anticancer agent bryostatin 1 activates platelets and neutrophils and modulates protein kinase C activityR L Berkow, L Schlabach, R Dodson, et al.
Journal of Clinical Microbiology|October 17, 1998
Comparison of the MB/BacT system with a revised antibiotic supplement kit to the BACTEC 460 system for detection of mycobacteria in clinical specimensW H Benjamin, K B Waites, A Beverly, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|November 25, 2003
Association between antecedent intravenous antimicrobial exposure and isolation of vancomycin-resistant enterococciL S Chavers, S A Moser, E Funkhouser, et al.
Current Topics in Microbiology and Immunology|January 1, 1986
Genetic control of the susceptibility to pneumococcal infectionD E Briles, J Horowitz, L S McDaniel, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Infection and Immunity|September 19, 2000
Human C-reactive protein is protective against fatal Salmonella enterica serovar typhimurium infection in transgenic miceA J Szalai, J L VanCott, J R McGhee, et al.
Microbial Pathogenesis|September 11, 1992
A 'safe-site' for Salmonella typhimurium is within splenic polymorphonuclear cellsN E Dunlap, W H Benjamin, A K Berry, et al.
Chest|December 18, 2001
Value of Mycobacterium tuberculosis fingerprinting as a tool in a rural state surveillance programK G Dobbs, K H Lok, F Bruce, et al.
Cancer Research|April 25, 1992
In vivo administration of bryostatin 1, a protein kinase C activator, decreases murine resistance to Salmonella typhimuriumA S Kraft, V Adler, P Hall, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 28, 1999
Spot sputum screening: evaluation of an intervention in two homeless sheltersM E Kimerling, C F Shakes, R Carlisle, et al.
International Journal of Antimicrobial Agents|December 12, 2001
In vitro activity of ABT-773, telithromycin and eight other antimicrobials against erythromycin-resistant Streptococcus pneumoniae respiratory isolates of childrenC N Johnson, W H Benjamin, B M Gray, et al.
Cancer Research|June 15, 1993
In vivo administration of the anticancer agent bryostatin 1 activates platelets and neutrophils and modulates protein kinase C activityR L Berkow, L Schlabach, R Dodson, et al.
Journal of Clinical Microbiology|October 17, 1998
Comparison of the MB/BacT system with a revised antibiotic supplement kit to the BACTEC 460 system for detection of mycobacteria in clinical specimensW H Benjamin, K B Waites, A Beverly, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|November 25, 2003
Association between antecedent intravenous antimicrobial exposure and isolation of vancomycin-resistant enterococciL S Chavers, S A Moser, E Funkhouser, et al.
Current Topics in Microbiology and Immunology|January 1, 1986
Genetic control of the susceptibility to pneumococcal infectionD E Briles, J Horowitz, L S McDaniel, et al.
Pageof 5